Back to search
FDAFDA · Food and drugs·Recall number D-0083-2018

TYVASO (treprostinil) Inhalation Solution Treprostinil 1.74 mg/2.9 mL (0.6 mg/mL) Tyvaso Inhalation System Starter Kit Model# TD-100/A, Rx Only, Manufactured by United Therapeutics Corporation Research Triangle Park, NC 27709, NDC# 6630220601

Published November 29, 2017 · Recall initiated: September 11, 2017

Summary

FDA records drug Class II recall D-0083-2018, published November 29, 2017 and initiated September 11, 2017. Recalling firm: United Therapeutics Corp.; Status: Terminated; Reported quantity: 12 devices; Lot: Lot #: 2101152; Exp. 12/11/2017 Lot #: 2101195; Exp. 04/26/2019. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
United Therapeutics Corp.
Distributor
PA
Lot
Lot #: 2101152; Exp. 12/11/2017 Lot #: 2101195; Exp. 04/26/2019
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was TYVASO (treprostinil) Inhalation Solution Treprostinil 1.74 mg/2.9 mL (0.6 mg/mL) Tyvaso Inhalation System Starter Kit Model# TD-100/A, Rx Only, Manufactured by United Therapeutics Corporation Research Triangle Park, NC 27709, NDC# 6630220601 recalled?

Yes. FDA published recall D-0083-2018 on November 29, 2017. Reported hazard: CGMP Deviations

What should I do if I have this product?

Voluntary: Firm initiated · Letter